Dermatology Times' Sunday Crossword: March 23, 2025

Welcome to Dermatology Times' Sunday Crossword, where dermatology knowledge meets fun! Each week, we curate a selection of words and terms pulled directly from the latest news in the dermatology world. Whether it's breakthrough treatments, new research findings, or emerging trends, this crossword serves as both a challenge and an opportunity to reinforce your expertise in the field.

For more in-depth insights, don't forget to check out our Weekly Roundup, where we break down the most important stories and updates from the past week. And to stay ahead of the curve and prepare for future crosswords, make sure to follow our content throughout the week.

Try out either our interactive crossword or a static/non-interactive version below.

Interactive Crossword

This crossword was created with CrosswordLabs.com.

Static/Non-Interactive Crossword

Across

4. Type of skin cancer linked to increased suicide risk in a recent review.

7. Agents used to break down excess keratin in conditions like psoriasis.

9. Chronic inflammatory skin condition (abbreviated) discussed in a Frontline Forum supplement.

10. Investigational therapy for chronic spontaneous urticaria.

Down

1. Type of laser found to be effective for acquired dermal melanocytosis.

2. Skin disease treated with ixekizumab in a long-term Japanese study.

3. AI-designed drug analyzed for efficacy across patient groups.

5. Hormone therapy linked to increased skin cancer risk.

6. Biologic therapy for AD associated with pediatric ocular adverse effects.

8. Abbreviation for a condition improved by mitochondrial complex I-blocking drugs.

For answers to this week's puzzle, check out next week's edition of the Dermatology Times Sunday Crossword.

Answers from our March 16, 2025 puzzle: [Across: 3- Effaclar; 5 - Cosentyx; 6 - Bunick; 7 - Bimzelx; 9 - NEA; Down: 1 - DMNA; 2 - microneedling; 3 - EltaMD; 4 - zonulin; 8 - Mohs]